6d agoSEC 8-KNEUTRAL 50General
PFIZER INC (PFE) files 8-K
Filed: 2026-08-04 AccNo: 0000078003-26-000094 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Archived explainer. For the current picture see today's PFE page.
Why Is PFIZER INC (PFE) Stock Moving Today?
By the Top Tier Newswire AI Desk · August 4, 2026 at 7:06 AM ET · reviewed against 16 wire stories
PFIZER INC (PFE) is drawing unusual attention today. Our newswire has captured 16 stories on PFE across 8 sources in the last 36 hours, with AI sentiment reading mixed (avg 54/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
PFE stock is moving slightly lower in early trading after Pfizer Inc. released second-quarter results and raised its 2026 revenue guidance. The stock opened at $25.12 and has traded down to $25.00, with a session high of $25.27 and a low of $25.00. The move reflects a mixed response to the company’s performance and forward-looking adjustments.
What Happened
Pfizer reported non-GAAP earnings per share of $0.77, beating estimates by $0.09, and revenue of $15.03 billion, exceeding expectations by $640 million. The company attributed the strong results to robust demand for its blood thinner Eliquis and other older drugs. In response, Pfizer raised the midpoint of its 2026 revenue guidance and announced $2.5 billion in additional cost savings through 2029. However, the firm also disclosed that its overall outlook for the year missed estimates. The SEC 8-K filing on August 4 confirmed the results and included updated financial statements.
What The Data Shows
The stock has traded within a narrow range during the session, with volume at 0.1 million shares, which is below the 3-month average. Over the past eight sessions, the stock has risen 0.3% from $25.07 to $25.16. The 52-week range is $23.11 to $28.75, and the stock has printed two fresh 52-week highs and 20 fresh 52-week lows on August 3. Recent insider activity includes a $51,000 sale by SVP Jennifer Damico on June 9. Congressional trades show Tommy Tuberville sold $15,001, $50,000 on June 8, while Donald J. Trump made small trades in late May.
What To Watch
Pfizer has no upcoming earnings date in the provided data. Investors should monitor the breadth of coverage as the 16 stories from 8 sources in the last 36 hours indicate active market interest.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PFE by the numbers
7 sessions: +3.99%Coverage: 16 stories / 8 sourcesAI sentiment: 54/100 (mixed)Mkt cap: $142.5BP/E: 19.152w: $23.11 to $28.75
The headlines behind the move
6d agoSeeking AlphaBEARISH 38Earnings
Earnings Snapshot: Pfizer targets $2.5B in added cost savings as outlook misses estimates
Earnings Snapshot: Pfizer targets $2.5B in added cost savings as outlook misses estimates
6d agoReutersBULLISH 68Earnings
Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis
6d agoBloombergBULLISH 68Earnings
Pfizer Raises Sales Guidance on Strong Demand for Older Drugs
6d agoSeeking AlphaBULLISH 68Earnings
Pfizer Non-GAAP EPS of $0.77 beats by $0.09, revenue of $15.03B beats by $640M
Pfizer Q2 results: EPS and revenue beat, adds $2.5B productivity savings, raises 2026 revenue guidance, and reaffirms EPS outlook—read the full update now.
6d agoStockTitanBULLISH 67Earnings
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
Launched and acquired products grew 18% operationally; Pfizer expects $2.5B in added savings from 2027-29, while COVID revenue is forecast at about $4B.
6d agoBarchartNEUTRAL 50General
PFE Aug 21 '26 20.00 Call Stock Options Overview History
Provides important summary options statistics to provide a forward looking indication of investors' sentiment, going back up to two years.
6d agoSeeking AlphaNEUTRAL 50Earnings
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include:Pfizer (PFE)Energy Transfer LP (ET)Merck & Co.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on PFE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier PFE move explainers: 2026-08-04 · 2026-07-29 · 2026-07-23 · 2026-07-20 · 2026-07-16 · 2026-07-13